Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-02

Clinical Trial Update: Hereditary Sensory Neuropathy Serine Trial [Phase 2]

View source ↗

Summary

Phase 2 trial update for hereditary sensory neuropathy type I; current status and sponsor information provided, no results yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University College, London | Conditions: Hereditary Sensory Neuropathy Type I | Phase 2 | Status: UNKNOWN